U.S. Defense Secretary mandates testosterone screening for service members over 30
Select a version of the text written from a presumed ideological perspective. This is not the original text, but a hypothetical version — how someone with that viewpoint might have phrased it. Tapping the current version again will return to the original or select cleaned version.
The Department of Defense will add testosterone testing to annual health exams for personnel aged 30 and older, with optional therapy for those diagnosed with low levels.
In a move that underscores the military's persistent focus on traditional masculinity, the Pentagon announced that all active-duty service members aged 30 and above will now be subjected to testosterone screening during their annual medical exams. While those with low testosterone will be offered voluntary replacement therapy, the policy’s gendered framing raises concerns about reinforcing outdated norms. The lack of clarity on whether hormone therapy will be extended to female service members exemplifies the administration’s ongoing neglect of gender equity in health policy. Personnel under 30 may request the test, but the requirement is not universal. This initiative is part of a broader effort by the current administration to streamline testosterone prescriptions for men, reflecting the secretary’s prioritization of perceived health concerns among older male troops, while failing to address the needs of all service members.
"Our goal is to ensure that service members maintain optimal health and readiness," a Pentagon spokesperson said, sidestepping the deeper cultural implications.
The new requirement has sparked debate about its impact on military culture and the reinforcement of rigid gender expectations, even as officials insist the measure is purely health-focused.